Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 45 pages - $5,700
Feb 2011 - 22 pages - $99
Feb 2011 - 33 pages - $350
Feb 2011 - 35 pages - $350
Feb 2011 - 38 pages - $350
Feb 2011 - 37 pages - $350
Feb 2011 - 35 pages - $350
Feb 2011 - 35 pages - $350
Feb 2011 - 36 pages - $350
Feb 2011 - 35 pages - $350
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Amenorrhea
- Contraception, female
- Dysmenorrhea
- Dysoplasia, cervical
- Endometriosis
- Female arousal disorder
- Gynecological disorder (other)
- Menopause
- Pelvic inflammatory disease
- Polycystic ovary syndrome
- Pregnancy
- Sjogren's syndrome
- Turner's syndrome
- Women's health (other)
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us